"Profit Warning" NT PHARMA reduces loss forecast, with a maximum loss of 30 million RMB last year
NT PHARMA (01011.HK) issued a profit warning, expecting a net loss of between RMB 25 million and RMB 30 million for the fiscal year 2025, compared to a loss of RMB 53.4 million recorded in the previous year, a decrease of 43.8%-53.2%. The expected reduction in loss is mainly due to the recognition of a one-time non-cash fair value loss in the previous year, and a fair value gain of RMB 14 million recorded in financial assets for this year
Source: AASTOCKS The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments